Century Therapeutics Mergers & Acquisitions

Century Therapeutics M&A Summary

Century Therapeutics has acquired 2 companies, including 2 in the last 5 years.

Century Therapeutics has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2

Century Therapeutics LLC

3675 Market Street,
Philadelphia, Pennsylvania 19104
United States,
www.centurytx.com

All (2) Buy (2) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2024-04-11 Clade Therapeutics · Life Science
Boston, Massachusetts · www.cladetx.com

Clade Therapeutics is a biopharmaceutical company focused on discovering and delivering engineerable, off-the-shelf, scalable, and consistent stem cell-based medicines. The company provides a robust cellular platform with stem-cell-derived immune cells for the treatment of cancer and autoimmune diseases. Clade Therapeutics is based in Boston, Massachusetts.

Advisor: Cooley
- Add-on Acquisition

Century Therapeutics LLC
Advisors: Goodwin Procter , Lazard

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.